These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32194015)

  • 1. Anti-corruption, Transparency and Accountability: Case Study of Healthcare in the Arab Countries.
    Hunter M; Uwaydah Mardini R; El-Seblani A; Elsayed S
    Glob Health Action; 2020; 13(sup1):1704529. PubMed ID: 32194015
    [No Abstract]   [Full Text] [Related]  

  • 2. Recalibrating the anti-corruption, transparency, and accountability formula to advance public health.
    Wierzynska A; Steingrüber S; Oroxom R; Bauhoff S
    Glob Health Action; 2020; 13(sup1):1701327. PubMed ID: 32194013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
    Vian T
    Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
    Kohler JC; Bowra A
    Global Health; 2020 Oct; 16(1):101. PubMed ID: 33081805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gateway Paper--context and configuration of the proposed health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S2-13. PubMed ID: 17595829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sustainable development goals as a framework to combat health-sector corruption.
    Mackey TK; Vian T; Kohler J
    Bull World Health Organ; 2018 Sep; 96(9):634-643. PubMed ID: 30262945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.
    Mackey TK; Cuomo RE
    Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014
    [No Abstract]   [Full Text] [Related]  

  • 9. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human rights mechanisms for anti-corruption, transparency and accountability: enabling the right to health.
    Sekalala S; Masud H; Bosco RT
    Glob Health Action; 2020; 13(sup1):1699343. PubMed ID: 32194016
    [No Abstract]   [Full Text] [Related]  

  • 11. Promoting anti-corruption, transparency and accountability in the recruitment and promotion of health workers to safeguard health outcomes.
    Kirya MT
    Glob Health Action; 2020; 13(sup1):1701326. PubMed ID: 32194012
    [No Abstract]   [Full Text] [Related]  

  • 12. Opening the Policy Window to Mobilize Action Against Corruption in the Health Sector Comment on "We Need to Talk About Corruption in Health Systems".
    Mackey TK
    Int J Health Policy Manag; 2019 Nov; 8(11):668-671. PubMed ID: 31779293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance.
    Wong A; Perehudoff K; Kohler JC
    Glob Public Health; 2024 Jan; 19(1):2350649. PubMed ID: 38752422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of governance in shaping health system reform: a case study of the design and implementation of new health regions in Ireland, 2018-2023.
    Schulmann K; Bruen C; Parker S; Siersbaek R; Conghail LM; Burke S
    BMC Health Serv Res; 2024 May; 24(1):578. PubMed ID: 38702678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploration of anti-corruption and health in international organizations.
    Bowra A; Saeed G; Gorodensky A; Kohler JC
    PLoS One; 2022; 17(8):e0269203. PubMed ID: 35917329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PREVENTION OF CORRUPTION OFFENCES IN THE HEALTHСARE: THE EXPERIENCE OF UKRAINE AND GEORGIA].
    Didkivska G; Kovalenko V; Fialka M; Samotiievych V; Sabadash I
    Georgian Med News; 2020 Nov; (308):185-191. PubMed ID: 33395665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corruption and health care system].
    Marasović Šušnjara I
    Acta Med Croatica; 2014 Jun; 68(3):243-6. PubMed ID: 26016214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good governance and budget reform in Lesotho Public Hospitals: performance, root causes and reality.
    Vian T; Bicknell WJ
    Health Policy Plan; 2014 Sep; 29(6):673-84. PubMed ID: 23293099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations.
    Gorodensky A; Bowra A; Saeed G; Kohler J
    BMJ Open; 2022 Dec; 12(12):e064137. PubMed ID: 36549737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of corruption in the health sector: theory, methods and interventions.
    Vian T
    Health Policy Plan; 2008 Mar; 23(2):83-94. PubMed ID: 18281310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.